戻る
Exact Sciences Corp (EXAS)価格
EXAS 株価推移チャート
EXAS 収入
Exact Sciences Corp
$102.43
0.08%
$0.09
終値： Jan 16, 16:00:00 GMT-5
$102.8
0.36%
$0.36
アフターマーケット：Jan 16, 20:00:00 GMT-5
B
最終スコア
主要データ
前終値
$102.34
始値
$102.35
当日レンジ
$102.3 - $102.8
52週レンジ
$38.81 - $102.8
取引高
1.5M
平均取引高
5.4M
1株当たり利益(TTM)
-5.32
配当利回り
--
時価総額
$19.5B
EXASとは何ですか？
EXACT Sciences Corp. is a cancer screening and diagnostics company. The company is headquartered in Madison, Wisconsin and currently employs 6,900 full-time employees. The company went IPO on 2001-01-30. The firm provides a portfolio of products for earlier cancer detection and treatment guidance. Its products and services focus on screening and precision oncology tests. The company is focusing its research and development efforts on three main areas: Colorectal Cancer Screening Test Development, MCED Test Development and MRD Test Development. Its products and services include Cologuard test, Oncotype DX Breast Recurrence Score Test, Oncotype DX Breast DCIS Score Test, Oncotype DX Colon Recurrence Score Test, OncoExTra Test, and Riskguard Test. Its flagship screening product, the Cologuard test, is a non-invasive, stool-based deoxyribonucleic acid (sDNA) screening test that utilizes a multi-target approach to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. The Oncotype DX Breast Recurrence Score test examines the activity of 21 genes in a patient’s breast tumor tissue.